Cromwell Property Group (ASX: CMW) – CMW Announces Latest Dividend Distribution
Cromwell Property Group has announced an ordinary distribution of 0.75 cents per security for the quarter ending 30 June 2026. The distribution will...
ASX Announcements
Nickel Industries (ASX: NIC) – Nickel Industries Files Second Operating Update
Nickel Industries delivered a compelling operational recovery in May 2026, with Adjusted EBITDA jumping to approximately US$51m despite softer...
Growthpoint Properties Australia (ASX: GOZ) – Growthpoint Continues Strong Leasing Momentum
Growthpoint Properties Australia has reported accelerating office leasing momentum in its trading update, with 54,721 square metres of directly held...
Sims (ASX: SGM) – Sims Files Trading Update 2026
Sims Limited has upgraded its FY26 underlying EBIT guidance to $420-435 million from the previously issued range of $350-400 million, a substantial...
Flight Centre Travel Group (ASX: FLT) – FLT Amends FY26 Guidance Announces Buyback
Flight Centre Travel Group has downgraded its FY26 profit guidance to $275m-$295m UPBT, a material reduction from the previous $310m-$345m range,...
Fletcher Building (ASX: FBU) – FBU June 2026 Trading Update
Fletcher Building has signaled a significant shift in its capital strategy with news that it will withdraw its Moody's credit rating following a...
Qube Holdings (ASX: QUB) – Qube Announces Scheme Meeting Results
Qube Holdings Limited shareholders have delivered emphatic approval for the proposed acquisition by Rubik Australia Pty Limited, removing a key...
Goodman Group (ASX: GMG) – Goodman Group Announces Fourth Distribution
Goodman Group has announced a distribution of AUD 0.15 per stapled security for the half-year period ending 30 June 2026. The announcement...
Atlas Arteria (ASX: ALX) – Third Supplementary Targets Statement Released
Atlas Arteria has lodged its third supplementary target's statement with the ASX and ASIC, reiterating the independent directors' recommendation...
Clinuvel Pharmaceuticals (ASX: CUV) – CLINUVEL Files U.S. Form 20-F Report
CLINUVEL Pharmaceuticals has publicly filed its Form 20-F Registration Statement with the U.S. Securities and Exchange Commission, clearing a major...